Meningococcal Vaccines
SKU
MRR-430D42AA101A
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 5.45 billion
2030
USD 10.97 billion
2024
USD 5.95 billion
CAGR
10.50%

Meningococcal Vaccines Market by Type (Combination Vaccines, Conjugate Vaccines, Men B Vaccines), Category (Intramuscular, Subcutaneous), Dosage Type, Target Group, End-User - Global Forecast 2024-2030

[181 Pages Report] The Meningococcal Vaccines Market size was estimated at USD 5.45 billion in 2023 and expected to reach USD 5.95 billion in 2024, at a CAGR 10.50% to reach USD 10.97 billion by 2030.

Meningococcal Vaccines Market
To learn more about this report, request a free PDF copy
Meningococcal Vaccines Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Meningococcal Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Meningococcal Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Meningococcal Vaccines Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., AstraZeneca PLC, Bavarian Nordic A/S, Bharat Biotech Ltd., Bio-Manguinhos, Bio-Med (P) Limited, CanSino Biologics Inc., Chongqing Zhifei Biological Products Co., Ltd., Emergent BioSolutions Inc., GlaxoSmithKline PLC, Incepta Pharmaceuticals Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Nanolek, LLC, Novartis AG, Panacea Biotec Ltd., Petrovax Pharm, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Sinovac Biotech Ltd., SK bioscience, Taj Pharmaceuticals Limited, Vabiotech, and Walvax Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Meningococcal Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Combination Vaccines
      • MenHibrix
      • Menitorix
    • Conjugate Vaccines
      • Menactra
      • MenAfriVac
      • Meningitec
      • Menjugate
      • Menveo
      • NeisVac-C
      • Nimenrix
      • NmVac4-DT
    • Men B Vaccines
      • Bexsero
      • Trumenba
    • Polysaccharide Vaccines
      • Mencevax
      • Menomune
      • NmVac4
  • Category
    • Intramuscular
    • Subcutaneous
  • Dosage Type
    • Booster Vaccination
    • Primary Vaccination
  • Target Group
    • Adult
    • Preteen
    • Teenager
  • End-User
    • Hospital Pharmacies
    • Pediatric Clinic
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Meningococcal Vaccines Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Meningococcal Vaccines Market?
  3. What are the technology trends and regulatory frameworks in the Meningococcal Vaccines Market?
  4. What is the market share of the leading vendors in the Meningococcal Vaccines Market?
  5. Which modes and strategic moves are suitable for entering the Meningococcal Vaccines Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Increasing Incidence of Meningitis Across the World
        2. Rising R&D Activities and Vaccines Developments in the Pipeline
        3. Rising Immunization Programs and Government Initiatives for Meningococcal Diseases
      2. Restraints
        1. High Cost of Meningococcal Vaccines Production
      3. Opportunities
        1. Incidence of Bacterial Meningitis in Emerging Countries Coupled with Improvement in Surveillance System
        2. Elevation of Collaborations and Partnerships to Support the Development of the Vaccines
      4. Challenges
        1. Limitations and Side Effects Associated with Meningococcal Vaccines
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Meningococcal Vaccines Market, by Type
    1. Introduction
    2. Combination Vaccines
    3. Conjugate Vaccines
    4. Men B Vaccines
    5. Polysaccharide Vaccines
  7. Meningococcal Vaccines Market, by Category
    1. Introduction
    2. Intramuscular
    3. Subcutaneous
  8. Meningococcal Vaccines Market, by Dosage Type
    1. Introduction
    2. Booster Vaccination
    3. Primary Vaccination
  9. Meningococcal Vaccines Market, by Target Group
    1. Introduction
    2. Adult
    3. Preteen
    4. Teenager
  10. Meningococcal Vaccines Market, by End-User
    1. Introduction
    2. Hospital Pharmacies
    3. Pediatric Clinic
    4. Retail Pharmacies
  11. Americas Meningococcal Vaccines Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  12. Asia-Pacific Meningococcal Vaccines Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  13. Europe, Middle East & Africa Meningococcal Vaccines Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  14. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  15. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  16. List of Figures [Total: 26]
    1. MENINGOCOCCAL VACCINES MARKET RESEARCH PROCESS
    2. MENINGOCOCCAL VACCINES MARKET SIZE, 2023 VS 2030
    3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. MENINGOCOCCAL VACCINES MARKET DYNAMICS
    7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
    8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
    10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
    12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2023 VS 2030 (%)
    14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
    15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    17. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    18. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    19. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    20. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    21. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    24. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    25. MENINGOCOCCAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
    26. MENINGOCOCCAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Tables [Total: 830]
    1. MENINGOCOCCAL VACCINES MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    8. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    9. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    12. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    13. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENHIBRIX, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENITORIX, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
    18. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
    19. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    20. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    21. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENACTRA, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2018-2023 (USD MILLION)
    24. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENAFRIVAC, BY REGION, 2024-2030 (USD MILLION)
    25. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENINGITEC, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENJUGATE, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENVEO, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NEISVAC-C, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2018-2023 (USD MILLION)
    34. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NIMENRIX, BY REGION, 2024-2030 (USD MILLION)
    35. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4-DT, BY REGION, 2024-2030 (USD MILLION)
    37. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, BY REGION, 2024-2030 (USD MILLION)
    39. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    40. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    41. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2018-2023 (USD MILLION)
    42. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BEXSERO, BY REGION, 2024-2030 (USD MILLION)
    43. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2018-2023 (USD MILLION)
    44. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TRUMENBA, BY REGION, 2024-2030 (USD MILLION)
    45. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2018-2023 (USD MILLION)
    46. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY REGION, 2024-2030 (USD MILLION)
    47. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    48. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    49. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2018-2023 (USD MILLION)
    50. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENCEVAX, BY REGION, 2024-2030 (USD MILLION)
    51. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2018-2023 (USD MILLION)
    52. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY MENOMUNE, BY REGION, 2024-2030 (USD MILLION)
    53. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2018-2023 (USD MILLION)
    54. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY NMVAC4, BY REGION, 2024-2030 (USD MILLION)
    55. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    56. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    57. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2023 (USD MILLION)
    58. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2024-2030 (USD MILLION)
    59. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2023 (USD MILLION)
    60. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2024-2030 (USD MILLION)
    61. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    62. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    63. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, BY REGION, 2018-2023 (USD MILLION)
    64. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY BOOSTER VACCINATION, BY REGION, 2024-2030 (USD MILLION)
    65. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, BY REGION, 2018-2023 (USD MILLION)
    66. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRIMARY VACCINATION, BY REGION, 2024-2030 (USD MILLION)
    67. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    68. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    69. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2018-2023 (USD MILLION)
    70. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY ADULT, BY REGION, 2024-2030 (USD MILLION)
    71. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, BY REGION, 2018-2023 (USD MILLION)
    72. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PRETEEN, BY REGION, 2024-2030 (USD MILLION)
    73. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, BY REGION, 2018-2023 (USD MILLION)
    74. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY TEENAGER, BY REGION, 2024-2030 (USD MILLION)
    75. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    76. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    77. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
    78. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
    79. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2023 (USD MILLION)
    80. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2024-2030 (USD MILLION)
    81. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
    82. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
    83. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    84. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    85. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    86. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    87. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    88. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    89. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    90. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    91. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    92. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    93. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    94. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    95. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    96. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    97. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    98. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    99. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    100. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    101. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    102. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    103. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    104. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    105. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    106. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    107. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    108. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    109. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    110. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    111. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    112. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    113. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    114. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    115. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    116. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    117. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    118. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    119. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    120. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    121. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    122. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    123. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    124. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    125. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    126. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    127. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    128. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    129. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    130. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    131. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    132. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    133. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    134. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    135. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    136. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    137. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    138. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    139. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    140. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    141. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    142. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    143. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    144. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    145. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    146. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    147. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    148. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    149. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    150. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    151. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    152. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    153. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    154. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    155. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    156. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    157. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    158. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    159. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    160. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    161. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    162. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    163. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    164. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    165. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    166. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    167. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    168. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    169. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    170. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    171. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    172. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    173. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    174. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    175. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    176. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    177. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    178. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    179. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    180. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    181. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    182. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    183. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    184. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    185. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    186. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    187. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    188. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    189. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    190. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    191. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    192. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    193. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    194. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    195. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    196. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    197. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    198. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    199. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    200. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    201. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    202. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    203. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    204. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    205. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    206. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    207. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    208. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    209. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    210. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    211. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    212. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    213. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    214. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    215. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    216. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    217. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    218. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    219. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    220. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    221. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    222. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    223. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    224. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    225. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    226. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    227. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    228. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    229. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    230. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    231. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    232. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    233. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    234. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    235. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    236. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    237. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    238. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    239. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    240. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    241. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    242. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    243. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    244. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    245. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    246. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    247. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    248. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    249. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    250. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    251. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    252. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    253. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    254. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    255. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    256. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    257. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    258. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    259. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    260. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    261. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    262. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    263. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    264. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    265. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    266. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    267. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    268. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    269. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    270. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    271. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    272. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    273. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    274. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    275. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    276. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    277. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    278. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    279. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    280. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    281. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    282. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    283. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    284. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    285. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    286. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    287. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    288. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    289. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    290. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    291. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    292. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    293. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    294. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    295. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    296. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    297. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    298. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    299. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    300. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    301. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    302. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    303. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    304. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    305. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    306. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    307. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    308. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    309. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    310. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    311. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    312. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    313. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    314. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    315. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    316. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    317. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    318. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    319. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    320. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    321. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    322. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    323. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    324. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    325. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    326. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    327. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    328. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    329. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    330. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    331. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    332. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    333. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    334. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    335. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    336. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    337. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    338. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    339. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    340. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    341. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    342. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    343. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    344. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    345. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    346. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    347. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    348. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    349. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    350. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    351. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    352. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    353. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    354. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    355. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    356. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    357. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    358. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    359. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    360. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    361. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    362. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    363. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    364. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    365. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    366. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    367. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    368. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    369. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    370. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    371. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    372. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    373. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    374. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    375. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    376. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    377. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    378. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    379. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    380. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    381. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    382. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    383. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    384. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    385. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    386. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    387. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    388. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    389. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    390. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    391. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    392. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    393. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    394. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    395. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    396. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    397. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    398. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    399. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    400. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    401. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    402. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    403. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    404. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    405. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    406. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    407. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    408. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    409. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    410. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    411. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    412. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    413. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    414. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    415. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    416. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    417. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    418. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    419. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    420. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    421. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    422. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    423. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    424. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    425. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    426. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    427. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    428. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    429. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    430. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    431. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    432. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    433. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    434. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    435. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    436. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    437. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    438. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    439. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    440. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    441. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    442. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    443. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    444. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    445. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    446. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    447. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    448. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    449. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    450. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    451. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    452. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    453. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    454. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    455. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    456. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    457. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    458. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    459. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    460. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    461. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    462. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    463. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    464. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    465. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    466. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    467. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    468. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    469. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    470. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    471. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    472. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    473. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    474. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    475. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    476. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    477. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    478. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    479. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    480. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    481. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    482. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    483. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    484. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    485. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    486. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    487. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    488. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    489. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    490. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    491. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    492. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    493. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    494. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    495. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    496. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    497. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    498. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    499. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    500. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    501. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    502. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    503. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    504. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    505. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    506. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    507. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    508. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    509. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    510. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    511. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    512. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    513. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    514. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    515. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    516. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    517. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    518. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    519. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    520. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    521. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    522. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    523. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    524. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    525. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    526. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    527. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    528. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    529. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    530. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    531. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    532. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    533. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    534. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    535. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    536. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    537. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    538. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    539. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    540. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    541. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    542. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    543. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    544. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    545. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    546. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    547. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    548. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    549. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    550. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    551. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    552. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    553. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    554. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    555. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    556. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    557. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    558. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    559. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    560. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    561. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    562. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    563. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    564. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    565. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    566. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    567. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    568. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    569. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    570. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    571. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    572. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    573. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    574. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    575. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    576. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    577. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    578. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    579. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    580. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    581. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    582. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    583. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    584. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    585. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    586. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    587. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    588. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    589. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    590. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    591. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    592. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    593. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    594. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    595. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    596. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    597. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    598. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    599. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    600. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    601. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    602. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    603. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    604. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    605. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    606. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    607. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    608. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    609. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    610. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    611. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    612. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    613. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    614. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    615. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    616. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    617. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    618. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    619. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    620. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    621. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    622. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    623. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    624. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    625. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    626. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    627. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    628. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    629. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    630. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    631. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    632. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    633. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    634. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    635. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    636. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    637. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    638. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    639. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    640. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    641. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    642. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    643. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    644. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    645. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    646. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    647. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    648. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    649. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    650. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    651. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    652. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    653. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    654. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    655. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    656. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    657. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    658. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    659. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    660. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    661. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    662. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    663. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    664. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    665. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    666. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    667. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    668. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    669. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    670. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    671. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    672. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    673. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    674. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    675. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    676. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    677. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    678. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    679. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    680. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    681. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    682. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    683. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    684. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    685. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    686. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    687. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    688. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    689. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    690. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    691. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    692. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    693. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    694. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    695. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    696. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    697. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    698. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    699. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    700. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    701. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    702. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    703. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    704. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    705. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    706. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    707. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    708. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    709. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    710. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    711. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    712. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    713. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    714. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    715. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    716. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    717. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    718. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    719. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    720. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    721. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    722. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    723. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    724. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    725. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    726. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    727. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    728. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    729. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    730. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    731. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    732. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    733. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    734. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    735. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    736. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    737. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    738. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    739. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    740. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    741. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    742. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    743. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    744. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    745. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    746. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    747. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    748. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    749. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    750. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    751. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    752. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    753. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    754. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    755. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    756. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    757. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    758. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    759. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    760. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    761. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    762. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    763. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    764. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    765. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    766. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    767. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    768. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    769. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    770. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    771. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    772. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    773. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    774. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    775. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    776. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    777. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    778. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    779. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    780. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    781. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    782. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    783. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    784. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    785. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    786. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    787. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    788. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    789. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    790. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    791. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    792. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    793. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    794. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    795. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    796. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    797. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    798. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    799. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    800. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    801. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    802. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    803. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    804. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    805. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    806. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    807. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    808. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    809. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    810. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    811. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
    812. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
    813. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2018-2023 (USD MILLION)
    814. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY COMBINATION VACCINES, 2024-2030 (USD MILLION)
    815. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2018-2023 (USD MILLION)
    816. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CONJUGATE VACCINES, 2024-2030 (USD MILLION)
    817. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2018-2023 (USD MILLION)
    818. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY MEN B VACCINES, 2024-2030 (USD MILLION)
    819. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2018-2023 (USD MILLION)
    820. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY POLYSACCHARIDE VACCINES, 2024-2030 (USD MILLION)
    821. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2023 (USD MILLION)
    822. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2024-2030 (USD MILLION)
    823. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2023 (USD MILLION)
    824. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2024-2030 (USD MILLION)
    825. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2023 (USD MILLION)
    826. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2024-2030 (USD MILLION)
    827. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
    828. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
    829. MENINGOCOCCAL VACCINES MARKET SHARE, BY KEY PLAYER, 2023
    830. MENINGOCOCCAL VACCINES MARKET, FPNV POSITIONING MATRIX, 2023
  18. List of Companies Mentioned [Total: 26]
    1. Astellas Pharma Inc.
    2. AstraZeneca PLC
    3. Bavarian Nordic A/S
    4. Bharat Biotech Ltd.
    5. Bio-Manguinhos
    6. Bio-Med (P) Limited
    7. CanSino Biologics Inc.
    8. Chongqing Zhifei Biological Products Co., Ltd.
    9. Emergent BioSolutions Inc.
    10. GlaxoSmithKline PLC
    11. Incepta Pharmaceuticals Ltd.
    12. Merck & Co., Inc.
    13. Mitsubishi Tanabe Pharma Corporation
    14. Nanolek, LLC
    15. Novartis AG
    16. Panacea Biotec Ltd.
    17. Petrovax Pharm
    18. Pfizer Inc.
    19. Sanofi S.A.
    20. Serum Institute of India Pvt. Ltd.
    21. Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
    22. Sinovac Biotech Ltd.
    23. SK bioscience
    24. Taj Pharmaceuticals Limited
    25. Vabiotech
    26. Walvax Biotechnology Co., Ltd.
Frequently Asked Questions
  1. How big is the Meningococcal Vaccines Market?
    Ans. The Global Meningococcal Vaccines Market size was estimated at USD 5.45 billion in 2023 and expected to reach USD 5.95 billion in 2024.
  2. What is the Meningococcal Vaccines Market growth?
    Ans. The Global Meningococcal Vaccines Market to grow USD 10.97 billion by 2030, at a CAGR of 10.50%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.